FDA Adverse Event Other Summary report: N

ARCHITECT I2000 ANALYZER

MDR report key: 983682 · Received January 24, 2008

Report

Report Number
1628664-2008-00022
Event Type
Other
Date Received
January 24, 2008
Date of Event
January 4, 2008
Report Date
January 4, 2008
Manufacturer
ABBOTT MANUFACTURING, INC.
Product Code
CDZ
PMA / PMN Number
K983212
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INVESTIGATION SUMMARY: THE ACCOUNT STATED THEY WERE RECEIVING INCONSISTENT BHCG RESULTS. CUSTOMER STATED THAT THEY HAD NO PROBLEMS WITH OTHER ASSAYS. THE COMPLAINT TEXT INDICATES A PHYSICIAN QUESTIONED THE RESULT ON THE FIRST PT, AS THE PREVIOUS RESULT WAS MUCH HIGHER. NO IMPACT TO PT MGMT WAS REPORTED. PER THE COMPLAINT TEXT THE CUSTOMER'S STAT PROBE HAS NEVER BEEN REPLACED. THE CSS INSTRUCTED THE CUSTOMER TO REPLACE AND CALIBRATE THE STAT PROBE AND TO ALSO REPLACE ALL 6 WASH ZONE PROBES. THE CUSTOMER PERFORMED THE REQUESTED TROUBLESHOOTING HOWEVER THE CUSTOMER STILL EXPERIENCED AN ISSUE NEAR THE HIGH LIMIT OF THE ASSAY. THE CUSTOMER LAST CALIBRATED THE ASSAY (B)(6)2008 USING REAGENT LOT NUMBERS (B)(4) AND (B)(4).AND CALIBRATOR LOT NUMBERS (B)(4). AND (B)(4). THE CSS INSTRUCTED THE CUSTOMER TO LOAD THE ROUTINE BHCG ASSAY TO CHECK THE PERFORMANCE OF THE ASSAY. THE COMPLAINT TEXT STATES THE CUSTOMER PERFORMED THE REQUESTED TROUBLESHOOTING BUT DID NOT GET RESULTS IN THE RANGE OF THE HIGH LIMIT. THE COMPLAINT INDICATED THE LOW AND MIDDLE VALUES RECOVERED WERE ACCEPTABLE. THE CSS WAS TO FOLLOW-UP WITH THE CUSTOMER. THIS IS AN INITIAL REPORT. AN INVESTIGATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE. END OF REPORT.

Description of Event or Problem · 1

THE CUSTOMER STATES THAT THEY ARE HAVING ISSUES WITH REPRODUCIBILITY WHEN TESTING PTS WITH THE ARCHITECT BHCG ASSAY. THE CUSTOMER STATES THAT THE STAT BHCG ASSAY GENERATED A RESULT OF 175,000 MIU/ML FOR ONE PT, WHICH TESTED 14,900 MIU/ML ON A SAMPLE DRAWN 2 DAYS LATER THAT WAS QUESTIONED BY A PHYSICIAN. THIS SAMPLE WAS REPEATED YIELDING A RESULT OF 15,000 MIU/ML. A RERUN OF THE SAMPLE DILUTED 1:15 GENERATED A RESULT OF 136,000 MIU/ML. NO IMPACT TO PT MGMT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT I2000 ANALYZER CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY ANALYZER CDZ ABBOTT MANUFACTURING, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 NI Other (B)(4)